Recombinant Vaccinia Virus Administered Intravenously in Patients With Metastatic, Refractory Colorectal Carcinoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Irinotecan
Related studies linked through entity extraction aliases.
Trial of Docetaxel and Irinotecan (DI) for Recurrent or Refractory Bone and Soft Tissue Sarcomas.
- Status
- UNKNOWN
- Phase
- PHASE2
Study of Bevacizumab + mFOLFOX6 Versus Bevacizumab + FOLFIRI With Biomarker Stratification in Participants With Previously Untreated Metastatic Colorectal Cancer (mCRC)
- Status
- COMPLETED
- Phase
- PHASE2
Irinotecan Plus Brivanib in Metastatic Colorectal Cancer (CRC) Enriched for Elevated Levels of Plasma FGF
- Status
- TERMINATED
- Phase
- PHASE2
Antiangiogenic Therapy for Children With Recurrent Medulloblastoma, Ependymoma, ATRT and Rare CNS Tumors
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Study Of PI3K/mTOR Inhibitors In Combination With An Oral MEK Inhibitor Or Irinotecan In Patients With Advanced Cancer
- Status
- TERMINATED
- Phase
- PHASE1
Safety and Pharmacokinetics of Treating Liver Cancer With Drug-Eluting Beads
- Status
- TERMINATED
- Phase
- PHASE1
Cyclophosphamide, Doxorubicin, Vincristine w/ Irinotecan and Temozolomide in Ewings Sarcoma
- Status
- TERMINATED
- Phase
- PHASE2
A Trial of Irinotecan and BKM120 in Previously Treated Advanced Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Trial of ICM With or Without AZD2281 (Olaparib) in Patients With Advanced Pancreatic Cancer
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Irinotecan, Levofolinate, and 5-Fluorouracil (FOLFIRI) Plus Ramucirumab (IMC-1121B)
- Status
- COMPLETED
- Phase
- PHASE1
Study of REOLYSIN® in Combination With FOLFIRI and Bevacizumab in FOLFIRI Naive Patients With KRAS Mutant Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE1
Cap+Bev vs Cap+Iri+Bev 1st-line Therapy in mCRC
- Status
- UNKNOWN
- Phase
- PHASE3
Study of IRNEA (Irinotecan, Etoposide, Cytarabine) for Refractory or Relapsed Acute Leukemia in Children and Adolescents
- Status
- UNKNOWN
- Phase
- PHASE1
FOLFOXIRI Plus Panitumumab Patients With Metastatic KRAS Wild-Type Colorectal Cancer With Liver Metastases Only
- Status
- COMPLETED
- Phase
- PHASE2
Erbitux Study of CPT11, Oxaliplatin, UFToral Targeted Therapy
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy Study of Paclitaxel Versus Irinotecan in Patients With Recurrent or Metastatic Gastric Cancer Who Progress Following First-line Therapy
- Status
- UNKNOWN
- Phase
- PHASE3
RSHF in Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2
A Study in Second Line Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE3
First-line FOLFOXIRI In Combination With Bevacizumab For Metastatic Colorectal Cancer
- Status
- COMPLETED
- Phase
- PHASE2